Cart
sales@molnova.com
Decarboxy Moxifloxacin
CAS No. 1322062-57-6
Decarboxy Moxifloxacin( —— )
Catalog No. M26147 CAS No. 1322062-57-6
Decarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 89 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 204 | In Stock |
|
| 50MG | 298 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDecarboxy Moxifloxacin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDecarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin.
-
DescriptionDecarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxy quinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTrk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1322062-57-6
-
Formula Weight357.429
-
Molecular FormulaC20H24FN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@]12CN(C[C@@]1([H])NCCC2)c1c(F)cc2c(c1OC)n(ccc2=O)C1CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Emiliano Cocco, et al. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018 Dec;15(12):731-747.
molnova catalog
related products
-
Bacopaside IV
Bacopaside IV is a natural product for research related to life sciences.
-
Dendrobine
Dendrobine has a slight but demonstrable analgesic and antipyretic action.Dendrobine produces moderate hyperglycemia, diminishes cardiac activity in large doses, lowers the blood pressure.
-
Pedalitin
Pedalitin is a mixed-type inhibitor of tyrosinase. In the assay of α-glucosidase inhibition, rosmarinic acid is a competitive inhibitor, whereas both methyl rosmarinate and Pedalitin are mixed-type inhibitors.
